Dysautonomia has substantially impacted acute COVID-19 severity as well as symptom
burden after recovery from COVID-19 (long COVID), yet the underlying causes remain …

Among the plethora of debilitating neurological disorders of COVID-19 syndrome in
survivors, the scope of SARS-CoV-2-induced dysautonomia (DNS) is yet to be understood …

Patients with long COVID suffer from many neurological manifestations that persist for 3
months following infection by SARS-CoV-2. Autonomic dysfunction (AD) or dysautonomia is …

Introduction On March 11, 2020, the World Health Organization sounded the COVID-19
pandemic alarm. While efforts in the first few months focused on reducing the mortality of …

As global numbers of COVID-19 grow, chronic neurological symptoms, including those of
autonomic dysfunction, are being reported with increasing frequency. Mounting evidence …

Background Previous studies suggest that coronavirus disease 2019 (COVID-19) is a
systemic infection involving multiple systems, and may cause autonomic dysfunction …

Increasing numbers of COVID-19 patients, continue to experience symptoms months after
recovering from mild cases of COVID-19. Amongst these symptoms, several are related to …

Background We are facing the outburst of coronavirus disease 2019 (COVID-19) defined as
a serious, multisystem, disorder, including various neurological manifestations in its …

Objective: To report a case series of dysautonomia associated with COVID-19 infection.
Methods: This is a retrospective review of patients evaluated in the autonomic clinic at our …

Purpose Post-COVID-19 syndrome is a poorly understood aspect of the current pandemic,
with clinical features that overlap with symptoms of autonomic/small fiber dysfunction. An …